| Code | CSB-RA011868MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to MINT1526A, designed to specifically target ITGA5 (integrin alpha-5), a cell surface receptor that forms heterodimers with integrin beta-1 to create the fibronectin receptor α5β1. ITGA5 plays crucial roles in cell adhesion, migration, and survival by mediating interactions between cells and the extracellular matrix. This integrin is critically involved in angiogenesis, wound healing, and embryonic development. Aberrant ITGA5 expression and signaling have been implicated in various pathological conditions, including cancer progression, metastasis, and fibrotic diseases, where it contributes to tumor cell invasion, epithelial-mesenchymal transition, and neovascularization.
MINT1526A is a reference therapeutic antibody that has been investigated for its ability to inhibit integrin α5β1-mediated signaling pathways. This biosimilar antibody serves as a valuable research tool for investigating ITGA5 biology, studying integrin-dependent cellular processes, exploring tumor microenvironment interactions, and evaluating potential therapeutic strategies targeting integrin-mediated pathways in oncology and fibrosis research.
There are currently no reviews for this product.